Status:
RECRUITING
Remote Ischaemic Preconditioning in Transplantation (RIPTRANS)
Lead Sponsor:
Helsinki University Central Hospital
Collaborating Sponsors:
Finska Läkaresällskapet (funding)
Academy of Finland
Conditions:
Transplant Dysfunction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Remote ischemic preconditioning (RIPC) is a concept where remotely induced ischemia produces protection against ischemia-reperfusion injury in a remote organ. RIPC has been studied extensively in anim...
Eligibility Criteria
Inclusion
- Donor
- Brain-dead organ donor with a plan of harvesting at least one kidney
- Donor
Exclusion
- Haemodynamically unstable donor
- Age below 18 years
- Planned organ recipients are recruited to another prospective trial, which prevents participation in this trial.
- All organ recipients receiving organs (kidney, liver, pancreas-kidney, heart, lungs) from a randomized donor will be recruited providing that the recipient surgery is performed at Helsinki University Hospital, recipient is over 18 years old, and recipient gives written informed consent to participate in the trial.
Key Trial Info
Start Date :
March 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2042
Estimated Enrollment :
496 Patients enrolled
Trial Details
Trial ID
NCT03855722
Start Date
March 12 2019
End Date
February 1 2042
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki University Hospital
Helsinki, Finland, 00029